EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness
EZVIZ 4G & Wi-Fi Battery Camera Family Hot Debut JOHANNESBURG, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security landscape with
EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness
EZVIZ 4G & Wi-Fi Battery Camera Family Hot Debut RIYADH, Saudi Arabia, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security
Details on the timetable of the simplified tender offer on North Atlantic Energies shares
Paris, Jan. 30, 2026 (GLOBE NEWSWIRE) — NORTH ATLANTIC ENERGIES Details on the timetable of the simplified tender offer on North Atlantic Energies shares Paris,
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy